OTIC HYDROCEPHALUS

A Comprehensive 50-Mark Answer

1. DEFINITION

• Raised intracranial pressure (ICP) in the absence of a space-occupying lesion
• Normal CSF composition (acellular, normal glucose and protein)
• Normal ventricular size on imaging (no true hydrocephalus in the conventional sense)
• Associated with lateral/sigmoid sinus thrombosis in most cases

The term is a misnomer — there is no actual enlargement of the ventricular system. The condition was first described by Symonds (1931) and was later refined by subsequent authors.

2. HISTORICAL BACKGROUND

3. ETIOLOGY AND PREDISPOSING FACTORS

┌─────────────────────────────────────────────────────────────┐
│              PREDISPOSING CONDITIONS                        │
├─────────────────────────────────────────────────────────────┤
│  1. Acute Otitis Media (AOM)                               │
│  2. Chronic Suppurative Otitis Media (CSOM)                │
│  3. CSOM with Cholesteatoma (most dangerous)               │
│  4. Mastoiditis (acute/coalescent)                         │
│  5. Lateral/Sigmoid Sinus Thrombosis (most direct cause)   │
│  6. Jugular Vein Thrombosis                                │
└─────────────────────────────────────────────────────────────┘

4. PATHOPHYSIOLOGY

4.1 Mechanism — Step-by-Step

┌──────────────────────────────────────────────────────────────────┐
│                  PATHOPHYSIOLOGY FLOWCHART                       │
└──────────────────────────────────────────────────────────────────┘
            │
            ▼
   OTITIS MEDIA / MASTOIDITIS
   (AOM or CSOM ± Cholesteatoma)
            │
            ▼
   Infection spreads via:
   • Direct erosion of bone
   • Retrograde thrombophlebitis
   • Emissary veins (mastoid emissary)
            │
            ▼
   LATERAL (SIGMOID) SINUS THROMBOSIS
            │
     ┌──────┴──────────────────────┐
     ▼                             ▼
Thrombus propagates          Thrombus in
to jugular bulb /            superior petrosal sinus
jugular vein                 or cavernous sinus
     │                             │
     └──────────┬──────────────────┘
                ▼
   IMPAIRED CEREBRAL VENOUS DRAINAGE
                │
                ▼
   ↑ Sagittal sinus pressure
                │
                ▼
   IMPAIRED CSF ABSORPTION
   at arachnoid granulations
                │
                ▼
   ↑ INTRACRANIAL PRESSURE
   (CSF composition remains NORMAL)
   (Ventricles NOT enlarged)
                │
                ▼
   OTIC HYDROCEPHALUS
   (Benign Intracranial Hypertension
    associated with ear disease)

4.2 CSF Dynamics (Normal vs. Otic Hydrocephalus)

5. CLINICAL FEATURES

5.1 Symptoms

┌──────────────────────────────────────────────────────────────┐
│                 CLINICAL FEATURES                           │
├──────────────────┬───────────────────────────────────────────┤
│ SYMPTOM          │ MECHANISM                                 │
├──────────────────┼───────────────────────────────────────────┤
│ Headache         │ ↑ ICP — most common, severe, persistent   │
│ (most common)    │ bifrontal or generalized                  │
├──────────────────┼───────────────────────────────────────────┤
│ Visual symptoms  │ Papilledema → visual blurring             │
│ (critical)       │ Can lead to permanent visual loss         │
├──────────────────┼───────────────────────────────────────────┤
│ Diplopia         │ VI (abducens) nerve palsy — false         │
│                  │ localizing sign due to ↑ ICP             │
├──────────────────┼───────────────────────────────────────────┤
│ Vomiting         │ ↑ ICP → direct brainstem effect          │
├──────────────────┼───────────────────────────────────────────┤
│ Tinnitus         │ Pulsatile, related to venous sinus       │
│                  │ pathology                                 │
├──────────────────┼───────────────────────────────────────────┤
│ Altered sensorium│ Late sign — lethargy, stupor            │
└──────────────────┴───────────────────────────────────────────┘

5.2 Signs

• Papilledema — bilateral, hallmark sign (fundus examination mandatory)
• VIth cranial nerve palsy — lateral rectus palsy → convergent squint → diplopia (false localizing sign)
• Features of underlying otitis media — ear discharge, perforated TM, cholesteatoma
• Neck stiffness — if meningitis co-exists
• Kernig's sign — rare, if meningeal irritation

Cummings (6th ed): "Signs and symptoms of intracranial complications include persistent headache, lethargy, malaise, irritability, severe otalgia, fever, nausea and vomiting, as well as localizing neurologic symptoms such as blurred vision, papilledema, diplopia."

6. DIAGNOSIS

6.1 Diagnostic Criteria (Modified Dandy Criteria for Otic Hydrocephalus)

┌─────────────────────────────────────────────────────────────┐
│           DIAGNOSTIC CRITERIA                               │
├─────────────────────────────────────────────────────────────┤
│ 1. History of ear disease (otitis media/mastoiditis)        │
│ 2. Raised ICP (>200 mmH₂O on lumbar puncture)             │
│ 3. Normal CSF composition (cells, protein, glucose)        │
│ 4. Normal ventricular size on CT/MRI                       │
│ 5. Evidence of lateral sinus thrombosis on imaging         │
│ 6. Signs of ↑ ICP: papilledema, VIth nerve palsy          │
│ 7. No space-occupying lesion                               │
└─────────────────────────────────────────────────────────────┘

6.2 Investigations

INVESTIGATIONS FLOWCHART
         │
    ┌────┴────────────────────────┐
    ▼                             ▼
IMAGING STUDIES          CSF ANALYSIS
    │                             │
    ├── CT Scan (with contrast)   ├── Opening pressure ↑
    │   • Normal ventricles       ├── Cells: Normal
    │   • Empty delta sign        ├── Protein: Normal
    │   • Opacified mastoid       └── Glucose: Normal
    │   • Sinus thrombosis            (Critical — rules
    │                                  out meningitis)
    ├── MRI + MRV (gold standard)
    │   • Best for sinus thrombosis
    │   • Delta sign on T1
    │   • Flow void absent in
    │     thrombosed sinus
    │
    └── OTOLOGICAL WORKUP
        • Pure tone audiometry
        • Tympanometry
        • Culture & sensitivity
        • CT Temporal bone

CT Findings:

• "Empty delta sign" (or delta sign) — filling defect in the posterior part of superior sagittal sinus on contrast CT, representing thrombus
• Opacification of mastoid air cells
• Erosion of tegmen or sinus plate in cholesteatoma
• Normal ventricle size — key differentiating point

MRI/MRV Findings:

• Absent flow void in sigmoid/lateral sinus
• Thrombus appears hyperintense on T1-weighted MRI
• MR Venography (MRV) shows absent or reduced flow in sinus
• Enlarged optic nerve sheaths

7. DIFFERENTIAL DIAGNOSIS

8. TREATMENT

8.1 Management Flowchart

┌──────────────────────────────────────────────────────────────┐
│              MANAGEMENT OF OTIC HYDROCEPHALUS               │
└──────────────────────────────────────────────────────────────┘
                    │
         ┌──────────┴──────────────┐
         ▼                         ▼
  IMMEDIATE MEASURES          TREAT UNDERLYING
  (Medical)                   EAR DISEASE (Surgical)
         │                         │
  ┌──────┴───────┐         ┌───────┴────────────┐
  │              │         │                    │
  ▼              ▼         ▼                    ▼
IV Antibiotics  ↓ ICP  Myringotomy +      Mastoidectomy
(broad spectrum) meas.  Tympanostomy tube  (± cholesteatoma
  │              │      (drain middle ear)  removal)
  │         ┌────┴─────┐
  │         │          │
  ▼         ▼          ▼
Culture- Acetazo-   Repeated
directed  lamide   Lumbar
therapy   (500mg    Puncture
          BD)       (lower ICP)
          │
          ▼
     Steroids
     (Dexameth-
      asone)
          │
          ▼
     Furosemide
     (adjunct)

8.2 Medical Management

• IV Ceftriaxone 2g BD (crosses blood-brain barrier)
• Metronidazole (for anaerobes in CSOM/cholesteatoma)
• Adjust based on culture sensitivity

• Acetazolamide (carbonic anhydrase inhibitor) — 250–500 mg BD/TDS — drug of choice to reduce CSF production
• Repeated lumbar puncture — to decompress (temporary but effective)
• Dexamethasone — 0.15 mg/kg/dose 6-hourly — reduces cerebral edema
• Furosemide — adjunct to acetazolamide
• Mannitol — 0.25–1 g/kg IV — for acute ↑ ICP

• Serial visual field testing — critical to prevent permanent visual loss
• Visual evoked potentials

8.3 Surgical Management

┌────────────────────────────────────────────────────────────┐
│               SURGICAL APPROACH                            │
├────────────────────────────────────────────────────────────┤
│ AOM + Otic Hydrocephalus:                                 │
│   → Myringotomy + Grommet insertion                       │
│   → IV antibiotics                                        │
│                                                            │
│ CSOM (tubotympanic) + Otic Hydrocephalus:                │
│   → Cortical Mastoidectomy + Tympanostomy                 │
│                                                            │
│ CSOM (atticoantral/Cholesteatoma) + Otic Hydrocephalus:  │
│   → Modified Radical Mastoidectomy                        │
│   → Cholesteatoma removal                                 │
│   → Sigmoid sinus decompression if thrombosed             │
└────────────────────────────────────────────────────────────┘

• Surgical drainage of perisinusal abscess
• Ligation of jugular vein (controversial; done if septic emboli)
• Needle aspiration of thrombosed sinus (historical)
• Anticoagulation — heparin (controversial; used if no hemorrhagic conversion)

• Optic nerve sheath fenestration — prevents visual loss
• Lumboperitoneal shunt — if refractory raised ICP

9. COMPLICATIONS OF UNTREATED OTIC HYDROCEPHALUS

       OTIC HYDROCEPHALUS (untreated)
               │
    ┌──────────┼──────────────┐
    ▼          ▼              ▼
BLINDNESS   BRAIN       DEATH (rare
(optic       HERNIATION   with modern
atrophy)     (tonsillar)   treatment)
    │
Permanent
visual loss
(most feared
complication)

• Permanent visual loss — most feared complication (due to optic atrophy from chronic papilledema)
• Cerebral herniation
• Septic emboli from sinus thrombosis → lung abscess, brain abscess
• Death (if untreated)

10. PROGNOSIS

• Good if diagnosed and treated early
• Risk of permanent visual impairment if papilledema is prolonged (>weeks)
• Complete recovery expected with prompt treatment of underlying ear disease + ICP reduction
• Regular ophthalmologic follow-up mandatory

11. RELATIONSHIP WITH OTHER INTRACRANIAL COMPLICATIONS OF OTITIS MEDIA

┌─────────────────────────────────────────────────────────────────┐
│        INTRACRANIAL COMPLICATIONS OF OTITIS MEDIA              │
│                  (Cummings Classification)                      │
├─────────────────────────────────────────────────────────────────┤
│                                                                 │
│  MENINGITIS                   ← Most common overall            │
│  EPIDURAL ABSCESS                                               │
│  SUBDURAL EMPYEMA                                               │
│  FOCAL OTITIC ENCEPHALITIS                                      │
│  BRAIN ABSCESS                ← Temporal lobe / Cerebellar     │
│  SIGMOID SINUS THROMBOSIS     ← Precedes otic hydrocephalus    │
│  OTIC HYDROCEPHALUS           ← Rare but treatable             │
│                                                                 │
│  MASTOIDITIS                  ← Extracranial (most common      │
│  BEZOLD'S ABSCESS               suppurative complication)      │
│  PETROSITIS (Gradenigo's)                                       │
└─────────────────────────────────────────────────────────────────┘

12. RECENT ADVANCES

12.1 Imaging Advances

• MR Venography (MRV) now gold standard for diagnosing dural sinus thrombosis
• CT Venography (CTV) — rapid, widely available alternative
• Digital subtraction angiography (DSA) — reserved for equivocal cases
• Diffusion-weighted MRI — detects associated brain ischemia

12.2 Treatment Advances

• Anticoagulation in dural sinus thrombosis — Low Molecular Weight Heparin (LMWH) now widely accepted; several prospective studies support its safety even in the presence of hemorrhagic infarction
• Endovascular thrombolysis — direct catheter-directed thrombolysis into sinus for refractory cases (emerging)
• Venous sinus stenting — for cases of stenosis-related intracranial hypertension
• Minimally invasive mastoidectomy — endoscopic approaches reduce morbidity

12.3 Understanding Pathomechanism

• Recent studies (Quattrocchi et al., 2014; Verhagen et al., 2012) confirm arachnoid granulation dysfunction as the primary mechanism — not merely sinus obstruction alone
• Genetic predisposition to sinus thrombosis (Factor V Leiden, MTHFR mutations) now recognized as an additional risk factor

12.4 Pediatric Considerations

• Children are more susceptible — thinner temporal bone, larger mastoid emissary veins
• Pneumococcal vaccination has reduced incidence of AOM-related intracranial complications by ~50%
• Anti-coagulation protocols now well-established for pediatric dural sinus thrombosis

13. SUMMARY — EXAM QUICK REFERENCE

┌────────────────────────────────────────────────────────────────┐
│                    OTIC HYDROCEPHALUS                         │
│                     QUICK REFERENCE                           │
├────────────────────┬───────────────────────────────────────────┤
│ Definition         │ ↑ICP with normal CSF & normal ventricles  │
│                    │ due to ear disease                        │
├────────────────────┼───────────────────────────────────────────┤
│ Coined by          │ Symonds, 1931                             │
├────────────────────┼───────────────────────────────────────────┤
│ Most common cause  │ Lateral sinus thrombosis (from mastoiditis│
│                    │ or CSOM/cholesteatoma)                    │
├────────────────────┼───────────────────────────────────────────┤
│ Cardinal symptoms  │ Headache, diplopia (VI nerve), papilledema│
├────────────────────┼───────────────────────────────────────────┤
│ Key investigation  │ MRI+MRV; LP (↑ pressure, normal CSF)     │
├────────────────────┼───────────────────────────────────────────┤
│ Hallmark CT sign   │ Empty delta sign (sinus thrombosis)       │
├────────────────────┼───────────────────────────────────────────┤
│ Medical treatment  │ IV antibiotics + Acetazolamide + Serial LP│
├────────────────────┼───────────────────────────────────────────┤
│ Surgical treatment │ Mastoidectomy (treat source)              │
│                    │ ± Optic nerve sheath fenestration         │
├────────────────────┼───────────────────────────────────────────┤
│ Most feared compl. │ Permanent blindness (optic atrophy)       │
├────────────────────┼───────────────────────────────────────────┤
│ Misnomer because   │ Ventricles are NOT dilated                │
└────────────────────┴───────────────────────────────────────────┘

REFERENCES

1. Cummings Otolaryngology – Head and Neck Surgery, 7th Edition — Chapter: Intracranial Complications of AOM; pp. 3775–3778
2. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery, 8th Edition — Complications of Otitis Media
3. Stell and Maran's Textbook of Head and Neck Surgery, 4th Edition — Complications of Otitis Media
4. Dhingra P.L. — Diseases of Ear, Nose and Throat, 7th Edition — Chapter on Complications of CSOM
5. Hazarika P. — Textbook of ENT and Head-Neck Surgery, 3rd Edition
6. Zakir Hussain — Textbook of ENT, Clinical Approach chapter on intracranial complications
7. Symonds CP. — Otitic hydrocephalus. Brain. 1931;54:55–71
8. Corbett JJ, Mehta MP. — Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983
9. Einhorn A, Mizrahi EM. — Benign intracranial hypertension associated with ear infections in children. Arch Dis Child. 1978
10. Quattrocchi CC et al. — Cerebral venous thrombosis in adults: A systematic review. AJNR. 2014

Examiner's Note (RGUHS 50-Mark Pattern): This topic is typically asked as part of "Complications of CSOM" or "Intracranial Complications of Otitis Media." For full marks, always include: (1) Definition with the misnomer explanation, (2) Pathophysiology flowchart linking lateral sinus thrombosis → raised ICP, (3) Diagnostic criteria including LP findings with normal CSF, (4) the Empty Delta Sign on CT, (5) Management including acetazolamide as drug of choice, mastoidectomy as the definitive treatment, and (6) Prognosis emphasizing risk of permanent visual loss.